Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 18, 2025Journal of Pharmacy and Pharmacology

Novel molecular biomarkers in kidney diseases: bridging the gap between early detection and clinical implementation

View Full Paper
Ask AI
Bookmark
Share

Authors

BCBibha ChoudharyBPBhupendra PuriAGAnil Bhanudas Gaikwad

Discussion

Loading...

Member takes

Overview

Literature review highlights new biomarkers for early diagnosis in kidney diseases, suggesting improved clinical implementation.

Key Points

  • Emerging biomarkers may significantly enhance early diagnosis and monitoring of kidney diseases.
  • Recent findings indicate that non-invasive biomarkers can assist in the individualized management of kidney conditions.
  • The review covers a decade of literature on blood and urine biomarkers linked to kidney damage mechanisms.
  • Integration of novel biomarkers into clinical practice could improve long-term outcomes for patients with kidney diseases.

Cite This Study

Choudhary et al. (2025) studied this question.

synapsesocial.com/papers/68f396388da44caaba02c749https://doi.org/10.1093/jpp/rgaf096
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Novel Biomarkers for Kidney Disease: New Frontiers in Early Diagnosis and Monitoring2024 · 2 citations
  2. 2Emerging Biomarkers in Kidney Function Assessment: From Conventional Tests to Precision Diagnostics2026
  3. 3Emerging Urinary Biomarkers and Innovative Technologies for the Early Detection and Personalized Management of Chronic Kidney Disease2026 · 1 citations
  4. 4Triple Biomarkers in the Early Diagnosis of Acute Kidney Injury: a Comprehensive Review2025
  5. 5Chronic Kidney Disease in Diabetes: Biomarkers for Early Detection and Management2024 · 1 citations